default author photo

Katrin Sjoquist

The University of Sydney - NHMRC Clinical Trials Centre

ABN 15 211 513 464

Locked Bag 77

Camperdown, NSW 1450

Australia

  • The University of Sydney - NHMRC Clinical Trials Centre

SCHOLARLY PAPERS

1

DOWNLOADS

38

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Agitg Monarcc: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients with Ras and Braf Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (Agitg)

Number of pages: 68 Posted: 05 Nov 2024
matthew burge, David Espinoza, Lorraine Chantrill, Chris S. Karapetis, Christopher Steer, Jeff Cuff, Ratnesh Srivastav, Niall Tebbutt, Katrin Sjoquist, Eva Segelov, Alessandra Francesconi, Stephanie Winata, Jeanne Tie, Darshit Thaker, Timothy Price, Rahul Ladwa, Andrew Strickland, Warren Joubert, Rebecca Mercieca-Bebber, Sonia Yip, Ehtesham Abdi and Derrick Sui
affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, Shoalhaven District Memorial Hospital, Flinders University - Flinders Medical Centre, Border Medical Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, Austin Health, The University of Sydney - NHMRC Clinical Trials Centre, Monash University, affiliation not provided to SSRN, The University of Sydney - NHMRC Clinical Trials Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Adelaide, Princess Alexandra Hospital, Monash Medical Centre, Princess Alexandra Hospital, The University of Sydney - NHMRC Clinical Trials Centre, The University of Sydney, affiliation not provided to SSRN and The University of Sydney - NHMRC Clinical Trials Centre
Downloads 38 (1,222,651)

Abstract:

Loading...

metastatic colorectal cancer, chemotherapy, older patients, geriatric assessments, survival, panitumumab